CoChat

Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model

Open access
Geller, Melissa A., Knorr, David A., Hermanson, David A., Pribyl, Lee, Bendzick, Laura, Mccullar, Valarie, Miller, Jeffrey S., Kaufman, Dan S. · 2013 · Cytotherapy
Cited by 73

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background aims There is an urgent need for novel therapeutic strategies for relapsed ovarian cancer. Dramatic clinical antitumor effects have been observed with interleukin (IL)-2 activated natural killer (NK) cells; however, intravenous delivery of NK cells in patients with ovarian cancer has not been successful in ameliorating disease. We investigated in vivo engraftment of intraperitoneally (IP) delivered NK cells in an ovarian cancer xenograft model to determine if delivery mode can affect tumor cell killing and circumvent lack of NK cell expansion. Methods An ovarian cancer xenograft mouse model was established to evaluate efficacy of IP-delivered NK cells. Tumor burden was monitored by bioluminescent imaging of luciferase-expressing ovarian cancer cells. NK cell persistence, tumor burden and NK cell trafficking were evaluated. Transplanted NK cells were evaluated by flow cytometry and cytotoxicity assays. Results IP delivery of human NK cells plus cytokines led to high levels of circulating NK and was effective in clearing intraperitoneal ovarian cancer burden in xenografted mice. NK cells remained within the peritoneal cavity 54 days after injection and had markers of maturation. Additionally, surviving NK cells were able to kill ovarian cancer cells at a rate similar to pre-infusion levels, supporting that in vivo functionality of human NK cells can be maintained after IP infusion. Conclusions IP delivery of NK cells leads to stable engraftment and antitumor response in an ovarian cancer xenograft model. These data support further pre-clinical and clinical evaluation of IP delivery of allogeneic NK cells in ovarian cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcyt.2013.05.022

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 73

Metadata

Authors
Geller, M. A., Knorr, D. A., Hermanson, D. A., Pribyl, L., Bendzick, L., Mccullar, V., Miller, J. S., & Kaufman, D. S.
Venue
Cytotherapy
Publisher
Elsevier BV
Published
2013-10
Volume
15
Issue
10
Pages
1297-1306
ISSN
1465-3249 (ISSN-L)
OpenAlex
W2029144175
Cited by
73
References
2
FWCI
1.89
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model. https://app.cochat.ai/papers/10.1016/j.jcyt.2013.05.022
The paper
Geller, M. A., Knorr, D. A., Hermanson, D. A., Pribyl, L., Bendzick, L., Mccullar, V., Miller, J. S., & Kaufman, D. S. (2013). Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model. Cytotherapy. https://doi.org/10.1016/j.jcyt.2013.05.022

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.